First Wave BioPharma Inc.

NASDAQ: FWBI · Real-Time Price · USD
2.96
0.13 (4.59%)
At close: May 16, 2024, 10:00 PM

First Wave BioPharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-998.27K -1.26M -16.09M -7.29M -8.81M 5.57M -4.1M -3.43M -4.19M -4.07M -3.99M 4.39M -5.41M -9.63M -11.17M -30.4M -9.28M -7.69M
Depreciation & Amortization
n/a n/a 22.02K 29.33K 35.32K 12.29K 7.32K 7.32K 7.32K 7.32K 7.32K 7.32K 7.32K 7.32K 137.2K 138.26K 133.88K 132.91K
Stock-Based Compensation
n/a n/a -29.26K 189.41K 131.89K 271.36K 126.12K 263.33K 292.7K 358.32K 84.35K 91.64K 374.91K 218.23K 102.36K 182.41K 314.06K 772.24K
Other Working Capital
-423.55K n/a -1.2M -444.66K 74.89K -74.89K 519.54K 752.11K -9.72K 250.28K -643.14K -8.38M 224.63K 280.57K 14.09M 288.24K 688.47K 619.01K
Other Non-Cash Items
1.26M 440.99K 3.06M 1.73M 8.58M 4.58M 199.37K 92.09K 15.81K 15.53K 1.81M 14.98K 23.5K 142.19K 2.69M 123.55K -384.54K 1.03M
Deferred Income Tax
n/a n/a 15.03M 4.42M 4.26M -14.86M -165.77K n/a n/a n/a n/a n/a n/a n/a 3.77M n/a n/a n/a
Change in Working Capital
-314.23K n/a -685.88K -945.67K -451.15K 451.15K 494.53K -259.8K 1.11M 843.91K -3.51M -8.76M 416.81K 1.35M -1.39M 14.23M 3.59M 672.94K
Operating Cash Flow
-54.88K -818.63K 1.3M -1.86M -3.45M -3.75M -3.44M -3.33M -2.76M -2.85M -5.59M -4.25M -4.59M -7.91M -5.86M -15.73M -5.62M -5.07M
Capital Expenditures
n/a n/a 500K 500K n/a n/a -500K n/a n/a n/a n/a n/a n/a n/a 1.96K -1.25M -73.93K n/a
Cash Acquisitions
n/a n/a -88.17K -88.17K -88.17K 88.17K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a 88.17K 88.17K n/a 88.17K -500 n/a n/a n/a n/a n/a n/a n/a n/a n/a -9M n/a
Investing Cash Flow
n/a n/a 500K 500K -88.17K 88.17K -500K n/a n/a n/a n/a n/a n/a n/a 1.96K -1.25M -9.07M n/a
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
-163.43K -81.26K -240.97K -188.83K -104.2K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
163.43K 781.26K -5.01M -1.94M 4.5M 3.38M 4.36M 5.39M 1.93M 3.55M 5.52M 4.77M 76.38K 5.37M 6.82M 16.11M 10.78M 11.05M
Financial Cash Flow
n/a 700K -7.54M -2.12M 681.42K 3.38M 4.36M 5.39M 1.93M 3.55M 5.52M 4.77M 76.38K 5.37M 6.82M 16.11M 10.78M 11.05M
Net Cash Flow
-54.88K -118.64K -3.25M -3.04M -2.75M -279.86K 419.44K 2.06M -828.38K 701.53K -294.1K 523.51K -4.54M -2.55M 1.04M -863.85K -3.95M 5.96M
Free Cash Flow
-54.88K -818.63K 1.8M -1.36M -3.45M -3.75M -3.94M -3.33M -2.76M -2.85M -5.59M -4.25M -4.59M -7.91M -5.86M -16.98M -5.7M -5.07M